What are the recommended vasopressor dosages (norepinephrine, epinephrine, phenylephrine, dopamine, and vasopressin) for achieving a target mean arterial pressure of ≥65 mmHg in hypotensive patients?

Recommended Vasopressor Dosages for Target MAP ≥65 mmHg

Start norepinephrine at 0.05-0.1 mcg/kg/min (approximately 3.5-7 mcg/min in a 70 kg adult) and titrate every 10-15 minutes to achieve MAP ≥65 mmHg, with vasopressin 0.03 units/min added when norepinephrine reaches moderate doses rather than escalating norepinephrine beyond 0.5 mcg/kg/min.

First-Line Vasopressor: Norepinephrine

Norepinephrine is the unequivocal first-choice vasopressor for hypotensive patients requiring vasopressor support 1. The Surviving Sepsis Campaign 2016 guidelines provide a strong recommendation with moderate quality evidence for this approach.

Starting Dose and Titration Strategy

The evidence supports starting norepinephrine at 0.05-0.1 mcg/kg/min based on severity of hypotension 2, 3:

• For moderate hypotension (MAP 53-65 mmHg): Start at 0.025-0.05 mcg/kg/min
• For severe hypotension (MAP <53 mmHg): Start at 0.1 mcg/kg/min to achieve faster MAP response 3

Recent 2026 data demonstrates that lower starting doses (0.025 mcg/kg/min) fail to achieve MAP ≥65 mmHg within 60 minutes when baseline MAP is below 53.9 mmHg, and this delay is independently associated with increased ICU mortality 3. Higher initial doses produce both larger and faster MAP increases, which is critical for patients with severe hypotension.

Titration protocol 2:

• Adjust every 10-15 minutes in increments of 0.05-0.2 mcg/kg/min
• Target MAP ≥65 mmHg initially
• After hemodynamic stabilization, wean incrementally over 12-24 hours

Practical Dosing for 70 kg Adult

• Starting range: 3.5-7 mcg/min (0.05-0.1 mcg/kg/min)
• Maximum recommended as monotherapy: ~35 mcg/min (0.5 mcg/kg/min) before adding second agent 4

Second-Line Vasopressor: Vasopressin

Add vasopressin 0.03 units/min (fixed dose) when norepinephrine requirements are moderate rather than continuing to escalate norepinephrine 1. The 2016 Surviving Sepsis guidelines suggest adding vasopressin with the intent of either raising MAP to target or decreasing norepinephrine dosage (weak recommendation, moderate quality evidence).

Key Vasopressin Principles

• Fixed dose: 0.03 units/min (do NOT titrate) 1
• Never use as sole initial vasopressor 1
• Doses >0.03-0.04 units/min reserved for salvage therapy only 1
• Emerging evidence suggests earlier initiation at lower norepinephrine doses may be beneficial 5, though guidelines have not yet incorporated this

Alternative/Additional Vasopressors

Epinephrine

Dosing: 0.1-0.5 mcg/kg/min (7-35 mcg/min in 70 kg adult) 4

• Add to or substitute for norepinephrine when additional agent needed 1
• Weak recommendation, low quality evidence for routine use in septic shock 1
• Particularly useful for severe hypotension (SBP <70 mmHg) 4

Dopamine

Dosing: 5-10 mcg/kg/min 4

• Use ONLY in highly selected patients with low risk of tachyarrhythmias and absolute/relative bradycardia 1
• Weak recommendation, low quality evidence 1
• Do NOT use low-dose dopamine for renal protection (strong recommendation against) 1

Phenylephrine

Dosing: 0.5-2.0 mcg/kg/min (35-140 mcg/min in 70 kg adult) 4, 6

• NOT recommended except in specific circumstances 1:
  • Norepinephrine causes serious arrhythmias
  • Cardiac output known to be high with persistently low BP
  • Salvage therapy when other agents fail
• Pure alpha-agonist without beta effects

Critical Implementation Points

MAP Target Considerations

Initial target: MAP ≥65 mmHg for all patients 1, 7. However, individualization is essential 7:

• Higher MAP targets (70-80 mmHg) may benefit patients with:

  • History of chronic hypertension who show clinical improvement with higher BP 1, 7
  • High central venous pressure values 1

• Lower MAP targets (50-60 mmHg) may be appropriate for:

  • Traumatic hemorrhagic shock with uncontrolled bleeding (without traumatic brain injury) 7

Administration Safety

All vasopressors should be administered via central line when possible 4 due to risk of tissue necrosis with extravasation. If extravasation occurs, infiltrate 5-10 mg phentolamine diluted in 10-15 mL saline immediately 4.

Do NOT mix adrenergic drugs with sodium bicarbonate or alkaline solutions - they are inactivated in alkaline environments 4.

Monitoring Requirements

Arterial catheter placement is recommended as soon as practical for all patients requiring vasopressors 1, 7.

Common Pitfalls to Avoid

1. Starting norepinephrine too low in severe hypotension - doses of 0.025 mcg/kg/min are insufficient when MAP <54 mmHg 3

2. Escalating norepinephrine indefinitely - add vasopressin at moderate norepinephrine doses rather than pushing beyond 0.5 mcg/kg/min 1, 8

3. Using dopamine routinely - reserve only for bradycardic patients at low risk for arrhythmias 1

4. Delaying vasopressor initiation - early norepinephrine administration achieves MAP targets faster and may reduce fluid overload 8, 9

5. Using vasopressin as monotherapy - always combine with norepinephrine 1

6. Titrating vasopressin dose - use fixed 0.03 units/min only 1